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Animals employ two systems for the de novo biosyn-
thesis of fatty acids: a megasynthase complex in the
cytosol (type I) that produces mainly palmitate, and
an ensemble of freestanding enzymes in the mito-
chondria (type II) that produces mainly octanoyl
moieties. The acyltransferases responsible for initia-
tion of fatty acid biosynthesis in the two compart-
ments are distinguished by their different substrate
specificities: the type I enzyme transfers both the
acetyl primer and the malonyl chain extender,
whereas the type II enzyme is responsible for trans-
location of only the malonyl substrate. Crystal struc-
tures for the type I and II enzymes, supported by
in silico substrate docking studies and mutagenesis
experiments that alter their respective specificities,
reveal that, although the two enzymes adopt a similar
overall fold, subtle differences at their catalytic
centers account for their different specificities.
INTRODUCTION
The de novo biosynthesis of fatty acids is accomplished employ-
ing an ensemble of iteratively acting enzymes that elongate an
acetyl precursor by the sequential addition of two-carbon units
derived from malonyl moieties. The constituent enzymes are
found in two distinct architectural forms. In prokaryotes and
plant chloroplast, the catalytic components are freestanding
monofunctional proteins, whereas in the cytosol of fungi and
animals they are covalently linked in megasynthase complexes.
The two architectural forms are known as type II and type I,
respectively. Surprisingly, in recent years the simple association
of architectural type with phylogenetic status has had to be
revised as it has become clear that fungi and animals make fatty
acids using both the type I and the type II systems (Schweizer
and Hofmann, 2004; Zhang et al., 2005). In animals, the type I
cytosolic megasynthase is responsible for the synthesis of the
bulk of long-chain fatty acids used for energy storage or lipid
synthesis, particularly in the ‘‘lipogenic tissues’’ such as liverChemistry & Biology 16,and adipose (Clarke, 1993). The type II system, however, is
located in the mitochondrial matrix and closely resembles coun-
terparts found in prokaryotes and plant plastids (White et al.,
2005). Although a full appreciation of the physiological im-
portance of the mitochondrial system in animals has yet to be
established, one important role appears to be the generation
of eight-carbon acyl chains that are the precursors of lipoyl moie-
ties utilized for the posttranslational modification of several mito-
chondrial proteins (Gueguen et al., 2000; Schweizer and Hof-
mann, 2004; Witkowski et al., 2007). In both the type I and II
systems, fatty acyl moieties are assembled on a phosphopante-
theine thiol template that is covalently linked to an acyl carrier
protein (ACP) component. Both systems also utilize an acyltrans-
ferase to translocate the chain extender substrate, typically
a malonyl moiety, from CoA to ACP. However, the acyltransfer-
ase domain (MAT) associated with the type I animal FAS is
unusual in that it is also responsible for loading the primer
substrate, usually an acetyl moiety. We report here the crystal
structures of the type I and type II acyltransferases associated
with the cytosolic and mitochondrial fatty acid synthase systems
in humans. Supported by mutagenesis and in silico substrate
docking experiments, the study reveals the location of the
substrate-binding sites of the two acyltransferases.
RESULTS
Overall Structure of MT and MAT
The MAT domain crystallized in an asymmetric unit consisting of
four molecules (a–d) that could be superimposed with an rmsd of
0.39 A˚ for 397 Ca atoms (see Figure S1A available online); hence,
the molecules can be considered to be structurally identical. The
structure was solved to a resolution of 2.81 A˚. The MT crystallized
with two molecules in the asymmetric unit that could be superim-
posed with an rmsd of 0.36 A˚ for 308 Ca atoms (Figure S1B). This
structure was solved to a resolution of 1.55 A˚. Both MAT and MT
are active as monomeric enzymes (Rangan et al., 1991; Zhang
et al., 2003), so the arrangement of molecules in the crystal lattice
has no functional significance. Although the sequence identity
between them is only 18%, the two structures are strikingly
similar (Figure 1) and 308 Ca atoms can be superimposed with
an rmsd of 1.98 A˚. Both enzymes are composed of two subdo-
mains. The larger of these exhibits a typical a/b hydrolase fold667–675, June 26, 2009 ª2009 Elsevier Ltd All rights reserved 667
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Crystal Structures of Human Malonyltransferaseswith a multistranded parallel b sheet (four strands in MAT and five
strands in MT) surrounded by a helices. The smaller domain has
a ferredoxin-like fold containing a multistranded (three strands in
MAT and four strands in MT) antiparallel b sheet packed against
Figure 1. Comparison of the Three-Dimen-
sional Structures of the Acyltransferase
Components of the Human Type I Cytosolic
and Type II Mitochondrial Fatty Acid Syn-
thase Systems
The two structures were first superimposed and
then displayed side-by-side for clarity.
(A) The structure of MAT includes the flanking ami-
noterminal (yellow) and carboxyterminal (gray)
linkers that connect this domain to the adjacent
domains in the megasynthase, b-ketoacyl syn-
thase, and dehydratase, respectively.
(B) The structure of the processed MT component
of the mitochondrial fatty acid synthase with the
mitochondrial targeting sequence removed. In
both figures, the active site residues, histidine,
serine, and arginine are shown in green.
(C) Superimposition of the active sites of MAT
(orange) and MT (gray). The region of MAT around
Met499 was optimized as described in the Experi-
mental Procedures.
(D) Primary and secondary structure alignments of
the MAT and MT enzymes. The amino- and car-
boxyterminal linkers are colored yellow and gray,
respectively, and the three key active-site resi-
dues are marked with asterisks.
two distal a helices. The MAT domain of
the human FAS more closely resembles
its counterparts in the modular polyketide
synthases than it does the human mito-
chondrial enzyme. Thus, the enzyme
shares 26% sequence identity with the
acyltransferase domain from module 5
of the 6-deoxyerythonolide B synthase
(DEBS) (Tang et al., 2006) and the Ca
atoms of the two structures can be super-
imposed with a rmsd of 1.86 A˚ (297 Ca
atoms, linkers excluded). The human
mitochondrial MT, on the other hand, is
more closely related to the malonyltrans-
ferases involved in de novo fatty acid
biosynthesis in prokaryotes (Figure S2).
Indeed, the amino acid sequence is
33%, 27%, and 23% identical with its
Escherichia coli, Streptomyces coeli-
color, and Helicobacter pylori counter-
parts, respectively (Keatinge-Clay et al.,
2003; Serre et al., 1995; Zhang et al.,
2007), and the Ca atoms of the structures
can be superimposed with an rmsd of
1.5 A˚ (286 Ca atoms forE. coli, Figure S3).
The MAT Linker Regions
The MAT domain contains two additional
structural elements corresponding to the
amino- and carboxy-terminal linkers that connect the enzyme to
its adjacent catalytic domains in the complete FAS structure
(Figure 1). Although the aminoterminal linker is not particularly
well conserved in 17 animal FAS sequences (Figure S2), it is
668 Chemistry & Biology 16, 667–675, June 26, 2009 ª2009 Elsevier Ltd All rights reserved
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Crystal Structures of Human MalonyltransferasesTable 1. Catalytic Properties of Wild-Type and Mutant Enzymes
Enzyme Mutation Malonyl CoA Acetyl CoA
KM (mM) kcat (min
1) kcat/ KM KM (mM) kcat (min
1) kcat/ KM
MTa WT 3.1 ± 0.6 65.1 ± 6.1 21 - 0 -
R142Q 38.6 ± 9.6 0.13 ± 0.01 0.003 9.1 ± 1.25 0.37 ± 0.03 0.04
R142G 71.2 ± 21 0.17 ± 0.02 0.0023 32.2 ± 6.9 0.40 ± 0.05 0.012
R142A 1060 ± 99 0.37 ± 0.02 0.00035 32.9 ± 5.7 0.29 ± 0.04 0.009
MATb WT 1.9 ± 0.23 72 ± 0.5 37.9 3.9 ± 0.4 114 ± 3.6 29.2
R606A 16.2 ± 2.4 0.6 ± 0.048 0.037 1.8 ± 0.28 852 ± 12 473
Values represent means of at least 3 assays ± SD.
a Assayed at 20C.
b Assayed on the rat enzyme at 0C; data from Rangan et al. (1997).well structured and defined by a three-stranded b sheet packed
against two helices on the distal side. The carboxyterminal linker,
which is moderately well conserved in animal FASs, consists of
two helices and a coiled region that folds back and makes
contacts with the proximal side of the aminoterminal linker
region. The highly structured nature of the flanking linker regions
suggests that they do not act merely as flexible tethers, but serve
to position the domain in a precise orientation with respect to its
neighbors in the megasynthase.
Active Sites
In both the MAT and MT, the active site is located in a gorge
between the two subdomains where three key residues are posi-
tionally conserved: Ser581, His683, and Arg606 in the human
MAT and Ser117, His234, and Arg142 in the human mitochon-
drial MT (Figure 1). However, the channel leading to the active
site of the crystallographic structure of MAT (PDB code 2JFD)
was found to be blocked when compared to other structural
homologs. In the open unobstructed structures, a deep and
well-defined channel leads the substrate to the active site.
Superimposition of the MAT structure with MT (PDB code
2C2N) and E. coli FabD (PDB code 2G2Z) helped in the identifi-
cation of Met499 as the residue responsible for the blockage.
This region could be reliably remodeled, since there are several
homologous structures (e.g., 2C2N, 2G2Z, and 2VZ8) with an
open channel that could be used as templates. Remodeling of
the main-chain conformation around Met499 created a gorge
similar to that observed in all other structural homologs. The
binding pocket of the remodeled MAT extended further into
the gorge between the two subdomains than did the MT
substrate-binding pocket and consequently was considerably
larger (938 versus 587 A˚3). The arrangement of key residues
around the active site of the two enzymes is compared in
Figure 1C.
As in all acyltransferases, regardless of specificity, the active-
site serine residue benefits from its position at the aminoterminus
of an a helix where its nucleophilicity is enhanced by a helix
dipole effect. In addition, the conserved histidine residue is posi-
tioned within hydrogen-bonding distance of the active-site
serine, where it can abstract the proton from the hydroxyl and
potentiate the nucleophilic character of that residue. This role
for the active-site histidine has been validated by inhibitor and
mutagenesis experiments with the isolated MAT domain (Ran-
gan and Smith, 1996). An arginine residue is positionallyChemistry & Biology 16conserved in sequence alignments of all acyltransferases that
utilize malonyl moieties, and the two crystal structures reveal
that this residue is located in the active-site with the guanidinium
side-chain directed toward the serine nucleophile (Figure 1C).
Earlier mutagenesis experiments with the isolated MAT domain
suggested that the arginine residue played a critical role in
recognition of the malonyl substrate by interaction with the nega-
tively charged 3-carboxylate (Rangan and Smith, 1997).
Typically in serine active-site acyltransferases, on formation of
the tetrahedral intermediate, the negatively charged oxygen
of the substrate carbonyl is accommodated in an oxyanion
hole. The new crystal structures suggest that the oxyanion holes
for the two acyltransferases likely are formed by backbone
amides of Met499 and Leu582 in MAT and Gln34 and Val118 in
MT (Figure 1C). Met499 is part of a Gly-Met-Gly motif that is
positionally conserved in all animal type I FASs, whereas Gln34
is part of a Gly-Gln-Gly motif that is universally conserved in
type II MTs (Figure S2).
The essential role of Arg142 in malonyl binding to the MT is
illustrated by replacing this residue with glutamine, glycine, or
alanine (Table 1). All three mutants exhibited significantly
reduced catalytic activity and lowered affinity for malonyl-CoA;
consequently, catalytic efficiency (kcat/KM) was reduced by
more than four orders of magnitude (Table 1). Clearly, a positively
charged residue is necessary for the binding of the malonyl
group, as proposed earlier for MAT (Rangan and Smith, 1997).
The Arg to Ala substitution also increased both the affinity of
the MAT enzyme for its alternative substrate, acetyl-CoA, and
overall catalytic activity (Table 1). Unlike the MAT enzyme,
wild-type mitochondrial MT is completely inactive toward
acetyl-CoA in the standard kinetic assay (Table 1) and, in the
absence of an acceptor, is not radiolabeled when incubated
with [1-14C] acetyl-CoA (details not shown). Surprisingly,
replacement of Arg142 in MT actually induces activity toward
acetyl-CoA, so that all three mutants exhibited higher catalytic
efficiencies with acetyl- rather than malonyl-CoA (Table 1). In
this respect, the mitochondrial MT appears to differ from its
prokaryotic type II counterparts, since active-site arginine
mutants of the Streptomyces coelicolor malonyltransferase are
inactive toward acetyl-CoA (Koppisch and Khosla, 2003).
Compared with the activity of the wild-type MT toward its natural
malonyl-CoA substrate, or the activity of the MAT toward acetyl-
CoA, however, the activity of the mitochondrial MT mutants
toward acetyl-CoA was low. An additional difference between, 667–675, June 26, 2009 ª2009 Elsevier Ltd All rights reserved 669
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Crystal Structures of Human Malonyltransferasesthe bacterial and mitochondrial malonyltransferases is that
whereas acetyl-CoA is a weak competitive inhibitor of the bacte-
rial enzyme (Joshi and Wakil, 1971), even in 100-fold molar
excess, acetyl-CoA does not inhibit malonyl transfer by the mito-
chondrial enzyme (details not shown).
Substrate Docking Simulations
To optimize performance of the docking experiments, the region
around Met499 in MAT was remodeled as described earlier. The
CoA thioester substrates could be docked into the active sites of
the two acyltransferases in positions compatible with catalysis.
The substrates were positioned with the malonyl and/or acetyl
moiety inserted deep into the gorge between the two subdo-
mains and the CoA moiety on the surface at the entrance to
the binding pocket. In both the malonyl-CoA/MAT and ma-
lonyl-CoA/MT structures, the carbonyl oxygen is positioned in
the oxyanion hole with the phosphopantetheine sulfur atom posi-
tioned close to the active-site serine side-chain oxygen and the
backbone amide nitrogen atoms of Met499 in MAT and of Gln34
in MT. In both enzymes, the malonyl moiety was positioned such
that the 3-carboxylate formed a salt bridge with a terminal
nitrogen of the guanidinium side-chain at Arg606 in MAT and
at Arg142 in MT (Figures 2A and 2C, respectively).
Acetyl-CoA could also be docked into the MAT with the cyste-
amine part of the substrate similarly positioned as in the malonyl-
CoA/MAT structure (Figure 2B). However, in the absence of
a direct interaction with the Arg606 side-chain, the position of
the acetyl methyl group appears to be determined primarily
through hydrophobic interactions with the side-chains of neigh-
boring Phe682 and Phe553. A partial density for the Met499
side-chain was tentatively located in only one of the four MAT
molecules crystallized in the asymmetric unit (2JFD), so it is likely
that this residue enjoys considerable freedom of movement. It,
too, could contribute to acetyl binding through hydrophobic
interaction with the substrate methyl group. Indeed, in the mito-
chondrial MT and all other malonyl-specific, type II acyltrans-
ferases, this methionine is replaced by glutamine, a more polar
residue.
Although, in the various simulated MAT and MT enzyme-
substrate complexes, the CoA moiety was always positioned
at the entrance to the gorge between the two subdomains, the
exact location of the nucleotide portion, at the entrance to the
substrate-binding pocket, was quite variable and only the cyste-
amine portion was similarly located. This result implies that the
CoA nucleotide moiety may be unconstrained and does not
play an important role in substrate binding and is consistent
with the earlier finding that malonyl-N-hexanoylcysteamine and
malonyl-CoA are equally good substrates for this enzyme (Smith,
1982). Indeed, docking simulations with S-malonyl-N-hexylcys-
teamine and malonyl-CoA positioned the malonyl moiety in iden-
tical locations (Figure S4).
The results of the docking experiments clearly support the
proposed essential role for the guanidinium side-chains of
Arg606 and Arg142 in the binding of malonyl moieties by the
two enzymes. Nevertheless, earlier mutagenesis experiments
had shown that the arginine side-chain at position 606 in MAT
is not required for acetyl binding. In fact, rather surprisingly,
these studies revealed that replacement of the active-site
residue Arg606 with alanine dramatically increased activity of670 Chemistry & Biology 16, 667–675, June 26, 2009 ª2009 Elsevierthe enzyme toward acetyl and longer chain-length substrates
(Rangan and Smith, 1997). Thus, activity toward octanoyl and
decanoyl thioester substrates was increased by 650- and
4760-fold, respectively. In an attempt to identify possible cryptic
binding-sites for these longer acyl chains, we performed docking
experiments of an Arg606Ala mutant with various CoA thioest-
ers. Malonyl-CoA could not be satisfactorily accommodated in
the active-site in the absence of the guanidinium side-chain,
consistent with the observation that the catalytic efficiency of
this mutant toward malonyl-CoA is reduced by three orders of
magnitude (Table 1), and further emphasizing the importance
of the guanidinium group for malonyl binding. In contrast, dock-
ing of acetyl-CoA into MAT was not impeded in the Arg606Ala
mutant. In fact, CoA thioesters containing up to 10 carbon atoms
in the acyl chain could be docked into the active site of this
mutant with their acyl chains extending deep into the gorge
between the two subdomains. Thus, these medium chain-length
acyl moieties are accommodated in the active site where the
Arg606 side-chain would be located in the wild-type enzyme
(Figure 3A). In the absence of the guanidinium side chain at
position 606, the substrate-binding pocket extends into a pre-
dominantly hydrophobic region defined by residues Phe553,
Leu582, Val585, Ala602, Ala603, Phe682, Leu694, Leu698,
Val736, and Leu739 (Figure 3B). Again, these findings are consis-
tent with earlier biochemical experiments that showed that
acyl moieties containing up to 10 carbon atoms were good
substrates for the Arg606Ala mutant, but not for the wild-type
enzyme (Rangan and Smith, 1997).
DISCUSSION
Structural analyses of the acyltransferase components of the
human cytosolic and mitochondrial FAS systems reveal that,
despite their association with radically different architectural
forms of FAS, these type I and type II enzymes adopt a similar
fold and utilize the same three conserved active-site residues,
a serine nucleophile and its supporting histidine and an arginine
essential for binding the malonyl substrate. The universal
conservation of these three residues in all type I and type II fatty
acid and polyketide synthases indicates that all of these
enzymes likely share the same catalytic mechanism. Neverthe-
less, the human MAT and MTs are distinguished by their different
substrate specificities in that the type I enzyme exhibits dual
specificity for both malonyl and acetyl moieties. Our results
suggest a possible structural basis for the different specificities.
In the simulated substrate dockings with MAT, the malonyl
substrate binds with the 3-carboxylate engaged in an ionic inter-
action with the guanidinium side chain of the active-site arginine
residue, whereas the acetyl moiety is stabilized by hydrophobic
interactions with Phe553, Phe682, and likely Met499. Malonyl
moieties bind to the mitochondrial MT in a similar manner with
Arg142 playing an essential role. However, in MT, the active-
site region is less hydrophobic with polar glutamine residues
(Gln34 and Gln85) replacing two of the residues implicated in
acetyl binding in MAT (Phe553 and Met499) (Figure 2D). The
absence of these hydrophobic residues in MT likely accounts
for the inability of MT to accept acetyl CoA as a substrate. The
substrate-binding pocket of MAT potentially extends deeper
into the gorge between the two subdomains than does that ofLtd All rights reserved
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Crystal Structures of Human MalonyltransferasesFigure 2. Stereo Models of the Acyltrans-
ferases with Substrates Docked Noncova-
lently in the Active Sites
(A) Malonyl-CoA docked in MAT.
(B) Acetyl CoA docked in MAT.
(C) Malonyl-CoA docked in MT.
(D) Superimposed substrate-binding pockets of
MAT (orange) and MT (gray).
Chemistry & Biology 16, 667–675, June 26, 2009 ª2009 Elsevier Ltd All rights reserved 671
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Crystal Structures of Human MalonyltransferasesFigure 3. Model of MAT R606A Mutant with Covalently Docked Decanoyl Moiety
(A) The decanoyl group is in thioester linkage with Ser 581. Replacement of Arg by Ala allows binding of the decanoyl chain. Location of Arg606 in the WT enzyme,
which obstructs entry of long acyl chains, is also shown for comparison.
(B) Interaction of the decanoyl chain (yellow) with hydrophobic side chains (green).the MT and, when the normal Arg606 side-chain is replaced with
alanine, the overall size of the binding pocket is extended from
938 to 1233 A˚3 allowing access to acyl chains containing as
many as 10 carbon atoms in the extended, hydrophobic cavity.
The fatty acid megasynthases found in the cytosol of fungi also
contain acyltransferases with different specificities. One acyl-
transferase is dedicated to loading the acetyl primer, whereas
the other has dual specificity for malonyl and palmitoyl moieties
(Schweizer and Hofmann, 2004). This enzyme is responsible
both for loading of the malonyl substrate and unloading of the
palmitoyl product, by transfer back to a CoA acceptor. In
contrast, the animal FAS unloads the palmitoyl product as
a free fatty acid through the action of a resident thioesterase
(Smith and Tsai, 2007).
Despite the overall similarity with the animal type I megasyn-
thases in terms of the chemical reactions catalyzed, the fungal
FASs are organized along completely different architectural
lines. Whereas the animal FASs are open, flexible structures,
the fungal FASs are rigid barrel-shaped structures in which
the constituent, covalently linked enzymes are embedded
in the interior walls (Smith, 2006). This difference is illustrated
by comparison of the human FAS MAT and the Thermomyces
lanuginosus malonyl/palmitoyl transferase (MPT) (Figure S5A).
The two catalytic domains adopt essentially the same fold
with the active-site serine, histidine, and arginine residues iden-
tically positioned. A striking difference is that the fungal enzyme
includes several structural appendages (shown in gray) that, in
the whole megasynthase, are responsible for anchoring the
enzyme in the wall of the barrel. Additional differences in
the topology of the substrate-binding pockets account for
the different specificities of the two enzymes. In MPT, the
substrate-binding pocket is located in a long groove at the672 Chemistry & Biology 16, 667–675, June 26, 2009 ª2009 Elseviersubdomain interface with a hydrophobic patch positioned
such that only acyl chains with 16–18 carbon atoms can bind
productively (Jenni et al., 2007; Leibundgut et al., 2007; Loma-
kin et al., 2007). In MAT, the binding pocket is relatively short
and in the Arg606Ala mutant can accommodate acyl chains
with a maximum of 10 carbon atoms. The fungal acetyl-specific
transferase (AT) also adopts a similar fold to other acyltrans-
ferases except that the binding pocket is much shorter and
the typical conserved arginine is replaced by an isoleucine
(Jenni et al., 2007; Leibundgut et al., 2007; Lomakin et al.,
2007). An additional residue close to the serine nucleophile,
Ile494, projects into the binding cavity, whereas in the MAT
structure, the positionally equivalent residue, Leu739, does
not (Figure S5B). These modifications may preclude binding
of malonyl moieties and longer chain-length acyl moieties in
the fungal acetyltransferase.
The MAT structure includes extensions at the amino- and car-
boxytermini that form part of the linkers that connect the enzyme
to its neighboring b-ketoacyl synthase and dehydratase
domains, respectively, in the cytosolic FAS. The structures of
these linker regions are remarkably similar to those flanking the
acyltransferase counterpart in module 5 of the 6-deoxyerythro-
nolide B synthase polyketide synthase, as revealed in the crystal
structure of the KSAT didomain (Tang et al., 2006) (Figure S6).
The aminoterminal linker structures of the FAS and DEBS acyl-
transferases can be aligned with an rmsd of 2.39 A˚. The only
difference is the presence of an additional helix that appears to
represents an insertion common to all six 6-deoxyerythronolide
B synthase modules but is absent from all documented FAS
sequences. This additional helix is located on the MAT side of
the linker and thus does not appear to make direct contact with
the adjacent b-ketoacyl synthase domain. The DEBSLtd All rights reserved
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Crystal Structures of Human Malonyltransferasesacyltransferase crystal structure, which includes the adjacent
b-ketoacyl synthase domain, reveals that both the amino- and
carboxyterminal linkers interact directly with the b-ketoacyl syn-
thase domain in an arrangement that likely would preclude signif-
icant movement of the two domains relative to one another.
The properties of human mitochondrial FAS enzymes
described thus far are remarkably similar to those of their type
II counterparts found in prokaryotes, consistent with the gener-
ally accepted endosymbiotic theory of mitochondrial origin,
and these common features should be taken into account
when evaluating the effectiveness of antibacterial agents that
target type II FAS enzymes. Nevertheless, the prokaryotic and
eukaryotic type II systems do have distinguishing features.
Whereas the prokaryotic systems use three different b-ketoacyl
synthases with overlapping specificities that range from
2-carbon to 16-carbon substrates (White et al., 2005), the mito-
chondrial system uses only one and has limited ability to elon-
gate beyond the 14-carbon stage (Zhang et al., 2005). The
prokaryotic type II system has a unique b-ketoacyl synthase III
that catalyzes the chain initiation step, using acetyl-CoA as
substrate (Tsay et al., 1992). In contrast, the mitochondrial type
II system appears to generate the acetyl primer by decarboxyl-
ation of malonyl moieties at the b-ketoacyl synthase (Christen-
sen et al., 2007; Yasuno et al., 2004; Zhang et al., 2005; Zhang
et al., 2003).
While this manuscript was under review, a 3.2 A˚-resolution
crystal structure was reported for the type I porcine FAS that
includes the entire MAT domain and its flanking linkers (Maier
et al., 2008). The porcine MAT structure is essentially identical
to that of the human counterpart reported here and the authors
also conclude that the unusual dual specificity of this enzyme
is due to the combined presence of the conserved arginine
residue and the hydrophobic nature of the active site.
SIGNIFICANCE
In Metazoans, for both the type I cytosolic and type II mito-
chondrial FASs, translocation of the substrates from CoA
thioester linkage to the acyl carrier protein is catalyzed
by acyltransferases. The type I acyltransferase transfers
both the acetyl primer and the malonyl chain extender,
whereas the type II enzyme is responsible for translocation
of only the malonyl substrate. Crystal structures and muta-
genesis studies of the human type I and II acyltransferases
have revealed the structural basis for their different specific-
ities. Both rely on the presence of guanidinium side chain in
the active site to anchor the 3-carboxylate of the malonyl
substrate. However, whereas binding of the acetyl substrate
by the type I enzyme is facilitated by an adjacent hydro-
phobic patch, acetyl binding in the type II enzyme is
precluded by the intrusion of two glutamine side-chains.
Unlike the type I system, the type II mitochondrial FAS
system lacks an acetyl transferase and therefore cannot
elongate an acetyl primer derived directly from acetyl-CoA.
Instead, this system relies on the decarboxylation of the
chain extending malonyl substrate to generate the primer.
In mitochondria, the concentration of acetyl-CoA is typically
1 mM (Lopaschuk, 2000; Roberts et al., 2005) and likely is
much higher than that of malonyl-CoA, so that this arrange-Chemistry & Biology 16,ment may ensure that acetyl moieties do not block the
pathway by saturating the available ACP pool.
EXPERIMENTAL PROCEDURES
Cloning, Expression,Mutagenesis, and Purification ofMitochondrial
MT and FAS-MAT
cDNAs coding for human MT and MAT(FAS) were obtained from the MGC clone
collection and were subcloned into a T7 based pET vector (pNIC28-Bsa4,
O. Gileadi, SGC Oxford). Site-directed mutagenesis of MT was performed
using the QuikChange site-directed mutagenesis kit (Stratagene), and
primers were from Elim Biopharmaceuticals (Hayward, CA). Authenticity of
mutants was confirmed by DNA sequencing. Plasmids encoding either wild-
type or mutant enzymes were transformed into E. coli strain BL21(DE3). Cells
were grown for24 hr at 30C in 1 l of Overnight Expression Instant TB Medium
(Novagen) in the presence of kanamycin (50 mg/ml). Cell pellets were collected
by centrifugation and stored at80C. Frozen cells were resuspended in 30 ml
of Buffer A (25 mM Tris-HCl [pH 7.8], 0.3 M NaCl, 2 mM Tris[2-carboxyethyl]
phosphine, and 10% glycerol [pH 7.8]) containing 5 mM imidazole. Lysis of cells
was performed at 4C in the presence of protease inhibitors (leupeptin 5 mg/ml,
trans-epoxysuccinyl-LGB 10 mM, pepstatin 1 mg/ml, and antitrypsin 5 mg/ml)
using a microfluidizer. The cell lysate was centrifuged at 12,0003 g for 1 hr at
4C, and the supernatant was passed through a 0.45 mm filter and applied to
a 1 ml HiTrap Chelating HP column (Amersham Biosciences). The column
was washed with Buffer A containing 50 mM imidazole, and then bound
proteins were eluted with 500 mM imidazole and concentrated using
a 10,000 MWCO Amicon device. All enzymes for kinetic analysis were stored
in aliquots at 80C in 25 mM Tris-HCl buffer (pH 7.8), 10% glycerol, 0.3 M
NaCl, 2 mM DTT, and 2 mM EDTA. For crystallization experiments, proteins
after IMAC were subjected to size-exclusion chromatography (Hiload 16/60
Superdex 200, GE Healthcare) in 10 mM HEPES (pH 7.5), 0.5 mM TECP, 5%
(MAT) or 10% (MT) glycerol, and 300 mM (MT) or 500 mM (MAT) NaCl. Correct
masses of the purified wild-type proteins were confirmed by ESI-TOF mass
spectrometry.
Measurement of Human Mitochondrial MT Activity
The standard assay was performed at 20C in 83 mM potassium phosphate
buffer (pH 6.8) (Zhang et al., 2003). Briefly, the reaction was initiated by the
addition of enzyme (0.05–10 mg, depending on enzyme activity) to buffer con-
taining 20 mM mitochondrial holo-ACP and 20 mM [2-14C] malonyl-CoA (Mora-
vek Biochemicals and Radiochemicals) and continued for 2 min. The reaction
was stopped by the addition of trichloroacetic acid. The precipitate of protein
was washed three times and used for determination of radioactivity. For eval-
uating activity toward acetyl-CoA, 20 mM [1-14C] acetyl-CoA was used as
a substrate. To measure binding of acetyl moieties in the absence of an
acceptor, ACP was omitted from the reaction mixture.
MAT and MT Structure Determination
Selection of suitable constructs for crystallization experiments was achieved
by screening panels of MAT and MT constructs having different amino- and
carboxytermini. A TEV-protease cleavable hexahistidine tag was encoded at
the aminoterminus of both the MAT and MT constructs. The MAT construct
chosen for crystallization encompassed FAS residues 422–823. This includes
the complete catalytic domain (residues 488–809) (Rangan et al., 1997),
together with the aminoterminal linker region beginning at residue 422, and
a short carboxyterminal extension to residue 823. The crystallized mitochon-
drial MT construct consisted of residues 69–375 and approximated the
mature, processed form of the protein with the aminoterminal targeting
sequence removed (Zhang et al., 2003), except that residues 376–390 were
also eliminated from the carboxyterminus.
Initial screens set up with native MAT yielded several hits. However, to
decrease crystal degradation by crystal handling, a condition was selected
that provided sufficient cryoprotection After optimization, diffraction quality
rod-like crystals were obtained from 20% PEG10K, 0.04 M Na/KPO4, and
25% glycerol with average dimensions 0.6*0.2*0.2 mm3, and were mounted
with a loop and flash-frozen by plunging into liquid nitrogen. Datasets were
collected at the PXII beamline at the Swiss Light Source using a MAR225667–675, June 26, 2009 ª2009 Elsevier Ltd All rights reserved 673
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MAT MT
PDB ID 2JFD 2C2N
Space group P212121 P21
Unit cell a = 85.98 A˚, b = 92.69 A˚, c = 159.87 A˚ a = 52.57 A˚, b = 84.83 A˚, c = 74.56 A˚, b = 93.43
Resolution 2.81 A˚ (2.90 A˚ – 2.81 A˚) 1.55 A˚ (1.65 A˚ – 1.55 A˚)
Completeness 98.4% (90.5%) 99.4% (96.5%)
Redundancy 4.0 (3.4) 4.0 (2.4)
I/s(I) 15.8 (2.4) 12.5 (2.3)
Rint 0.050 (0.410) 0.080 (0.280)
Number of atoms 11392 5479
Number of unique reflections 39706 92079
Rwork 0.212 0.178
Rfree 0.273 0.218
R.m.s.d bond lengths 0.011 A˚ 0.016 A˚
R.m.s.d bond angles 1.23 1.65
Values in parentheses are for data in highest resolution shell.detector at a wavelength of 0.9793 A˚. Selenomethionine-labeled protein could
be crystallized using the same crystallization condition, and crystals were anal-
ogous to the native in morphology and size but degraded after one week and
had to be mounted immediately after they appeared. A SAD dataset was
collected at the PXII beamline at the SLS, using the selenium peak wavelength
(0.9789 A˚, determined from a fluorescence scan). The diffraction pattern for
both the native and selenomethionine-labeled protein was highly anisotropic,
but images could be processed with XDS. Different scans were scaled
together using XSCALE. As a result of severe anisotropy, the anomalous signal
obtained from the selenomethione-labeled crystal was significant to 4.5 A˚ only.
However, this proved to be sufficient for SHELXD to locate 40 selenium posi-
tions. These were refined by SOLVE and solvent-flattened by RESOLVE to
yield an interpretable map. NCS operators could be derived from selenium
positions, but NCS averaging did not improve maps, possibly because of
translational-only symmetry. Although an initial model could be built, the
sequence could not be assigned, and refinement stalled. Phases obtained
from this model were therefore used as external phase information in SHARP,
which allowed the completion of the anomalous substructure by finding minor
selenium sites. Phases were solvent-flattened, and the model was rebuilt using
the new map. Phase restraints (solvent-flattened phases expressed as Hen-
drickson-Lattman coefficients) proved very useful to keep refinement stable
and improved maps significantly. After several rounds of rebuilding and refine-
ment, the new model was used to solve the higher resolution native dataset,
and was refined to convergence. Data processing and refinement statistics
are given in Table 2.
Crystals of MT were obtained using the sitting drop vapor diffusion method
at room temperature. Diffraction quality crystals grew from 32% PEG4K and
0.25 M Li2SO4 in Tris/HCl (pH 8.5). Data were collected at the PXII beamline
at the Swiss Light Source using a MAR225 detector at a wavelength of
1.0038 A˚. Frames were integrated and scaled with MOSFLM and SCALA.
Initial phases were calculated by molecular replacement using Phaser and
the structures of E. coli and Streptomyces coelicolor malonyl-CoA ACP trans-
acylases (1MLA and 1NM2, respectively) as an ensemble search model. Iter-
ative rounds of model building with COOT and refinement with refmac5
converged to the final model for which statistics are given in Table 2.
Structural Remodeling of MAT
Structure modeling was performed using ICM software. Superimposition of
the structures to be modeled (MAT PDB code 2JFD) and the templates
(PDB codes 2C2N, 2G2Z, and 2VZ8) was performed showing agreement in
the backbone conformation for all the templates. Tethers were set for atoms
of Met499 (2JFD, to be modeled) and corresponding atoms of Met499
(2VZ8, template). Main-chain torsion angles were set free for Met499 (2JFD)674 Chemistry & Biology 16, 667–675, June 26, 2009 ª2009 Elsevieand two flanking residues and then energy minimized with the inclusion of
the tethers parameter, which was overweighted (tzWeight parameter in
ICM = 100.00) to allow for fast convergence. The resulting main-chain confor-
mation of the loop was again energy minimized for Met499 and two flanking
residues, now without the inclusion of the tethered parameter to solve energy
strains created by the tethered modeling step. Finally, the side-chain of
Met499 was manually optimized to adopt a rotamer similar to that of the 3D
equivalents Gln11 (2G2Z) and Gln34 (2C2N). This was followed by a local
energy minimization of the side-chains in the vicinity to ensure the absence
of steric clashes.
Structural Analysis Methods
Calculation of the rmsd for Ca alignments was performed on-line using
MSDfold (SSM) at http://www.ebi.ac.uk/msd-srv/ssm/ssmstart.html. The
size of substrate-binding pockets was estimated using CASTp (Dundas
et al., 2006).
Substrate Docking In Silico
The ICM software (Molsoft LLC, La Jolla, CA) was used to perform docking
experiments. The substrates (malonyl-coenzyme A, MLZ, and acetyl-coen-
zyme A, ACO) were retrieved from the Hetero-compound Information Centre
Uppsala (release 12.1) (Kleywegt et al., 2003), converted to ICM internal
format, and processed (protonation, charge assignment, and 3D energy mini-
mization). Docking receptor structures (MT, PDB code 2C2N and MAT, modi-
fied model from 2JFD; see above) were also loaded into ICM, converted to ICM
internal format, processed (protonation and charge assignment), and regular-
ized (global optimization of bond lengths, angles, hydrogen bond network, and
removal of steric clashes). The ligands were then docked into the receptors
according to the docking protocol implemented in ICM (Abagyan et al.,
1994, 2008) without positional restraints. At least three docking experiments
were performed for each combination of receptor and ligand. The resulting
poses were visually inspected to identify those with the malonyl or acyl moiety
of the substrate positioned in a catalytically competent way (i.e., close to the
catalytic serine and histidine residues and the oxyanion hole). Once identified,
the poses were refined by allowing both the side-chains of the receptor and the
substrate to freely rotate and optimize the binding mode.
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Atomic coordinates have been deposited in the Protein Data Bank under ID
codes 2C2N (human mitochondrial malonyltransferase) and 2JFD (human fatty
acid synthase, malonyl/acetyl transferase domain).r Ltd All rights reserved
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